Significant milestone for the Dementia with Lewy Bodies community: new DLB trials moving to Phase 3; CervoMed aligned with the FDA on a registration path for neflamapimod.
#Dementia #LewyBodyDementia #DLB #ClinicalTrials #Phase3 #Neflamapimod
0
0
0
0